FDA Adverse Event Injury Summary report: N

VITALITY 2

MDR report key: 3052780 · Received April 11, 2013

Report

Report Number
2124215-2013-04170
Event Type
Injury
Date Received
April 11, 2013
Date of Event
February 26, 2013
Report Date
April 29, 2013
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE HAS BEEN EXPLANTED AND RETURNED. UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, A REVIEW OF DEVICE MEMORY REVEALED THAT THE DEVICE DECLARED ELECTIVE REPLACEMENT INDICATOR (ERI) AFTER EXPERIENCING TWO CONSECUTIVE CHARGE TIMES GREATER THAN THE EXTENDED MID-LIFE ERI CHARGE TIME LIMIT. THE OBSERVED RATE OF BATTERY USAGE WAS COMPARED TO THE EXPECTED RATE OF BATTERY USAGE; THE RESULTS INDICATED THAT THE MONITORING VOLTAGE WAS NORMAL. ALTHOUGH THE BATTERY ITSELF HAD NOT DEPLETED PREMATURELY, ERI WAS TRIGGERED EARLIER THAN EXPECTED BY EXTENDED CHARGE TIMES DUE TO A HIGHER-THAN-TYPICAL BUILDUP OF INTERNAL BATTERY IMPEDANCE.

Additional Manufacturer Narrative · 1

ALL AVAILABLE INFORMATION INDICATES THAT THIS PRODUCT REMAINS IN SERVICE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) IS AT ELECTIVE REPLACEMENT INDICATOR (ERI). THE HEALTH CARE PROFESSIONAL (HCP) IS CONCERNED THAT THE VOLTAGE DROPPED TOO FAST AND MAY CAUSE A SHORTENED TIME TO END OF LIFE (EOL). BOSTON SCIENTIFIC TECHNICAL SERVICES (TS) ADVISED THE DEVICE WENT TO ERI DUE TO EXTENDED CHARGE TIME (CT) AND NOT MONITORING VOLTAGE. TS CAUTIONED IF THE CHARGE TIME (CT) GETS ABOVE THIRTY SECONDS THERE WOULD ONLY BE MAXIMUM ENERGY SHOCKS AVAILABLE. THERE WERE NO ADVERSE PATIENT EFFECTS REPORTED.

Description of Event or Problem · 1

--

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
156484 VITALITY 2 IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND T167

Patients

Seq Age Sex Outcome Treatment
1 83 YR Hospitalization| L| R 4470| T167| 0185